Lexaria Bioscience Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lexaria bioscience daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lexaria Bioscience Daily Today - Breaking & Trending Today

Cowen AND Company LLC Purchases New Holdings in Lexaria Bioscience Corp. (NASDAQ:LEXX)

Cowen AND Company LLC purchased a new position in shares of Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 256,327 shares of the company’s stock, valued at approximately $320,000. Cowen AND Company LLC owned about 2.46% of […] ....

Lexaria Bioscience , Armistice Capital , Lexaria Bioscience Company Profile , Lexaria Bioscience Corp , Maxim Group , Free Report , Get Free Report , Visit Holdingschannel , Lexaria Bioscience Daily ,

FY2024 Earnings Forecast for Lexaria Bioscience Corp. Issued By Zacks Small Cap (NASDAQ:LEXX)

Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) – Research analysts at Zacks Small Cap lifted their FY2024 earnings estimates for shares of Lexaria Bioscience in a research report issued on Monday, April 29th. Zacks Small Cap analyst J. Vandermosten now anticipates that the company will earn ($0.46) per share for the year, up from their […] ....

Lexaria Bioscience , Lexaria Bioscience Company Profile , Lexaria Bioscience Corp , Welch Group , Armistice Capital , Maxim Group , Free Report , Zacks Small Cap , Small Cap , Get Free Report , Lexaria Bioscience Daily , Nasdaq Lexx , Earnings Estimates ,

Adial Pharmaceuticals (NASDAQ:ADIL) and Lexaria Bioscience (NASDAQ:LEXX) Financial Contrast

Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) and Adial Pharmaceuticals (NASDAQ:ADIL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Analyst Recommendations This is a summary of […] ....

United States , British Columbia , Lexaria Bioscience , Adial Pharmaceuticals Inc , Adial Pharmaceuticals , Lexaria Bioscience Corp , Get Free Report , Given Lexaria Bioscience , Adial Pharmaceutical , Lexaria Bioscience Daily , Nasdaq Lexx , Stock Comparison , Stock Analysis ,

Lexaria Bioscience (NASDAQ:LEXX) and Edesa Biotech (NASDAQ:EDSA) Head to Head Survey

Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) and Edesa Biotech (NASDAQ:EDSA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends. Volatility & Risk Lexaria Bioscience has a […] ....

British Columbia , Lexaria Bioscience , Lexaria Bioscience Corp , Edesa Biotech Inc , Yissum Research Development Company , Get Free Report , Edesa Biotech , Given Edesa Biotech , Lexaria Bioscience Daily , Nasdaq Lexx , Stock Comparison , Stock Analysis ,

Lexaria Bioscience Corp. (NASDAQ:LEXX) Position Raised by Invenomic Capital Management LP

Invenomic Capital Management LP raised its stake in Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) by 62.0% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 766,573 shares of the company’s stock after buying an additional 293,470 shares during the quarter. Invenomic Capital Management LP owned approximately 9.48% […] ....

Lexaria Bioscience , Susquehanna International Group , Virtu Financial , Lexaria Bioscience Corp , Dimensional Fund Advisors , Lexaria Bioscience Company Profile , Renaissance Technologies , Invenomic Capital Management , Free Report , Capital Management , International Group , Fund Advisors , Bioscience Stock Down , Visit Holdingschannel , Lexaria Bioscience Daily , Nasdaq Lexx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,